News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
507,121 Results
Type
Article (32951)
Company Profile (92)
Press Release (474078)
Multimedia
Podcasts (31)
Webinars (8)
Section
Business (140635)
Career Advice (927)
Deals (23646)
Drug Delivery (71)
Drug Development (64963)
Employer Resources (76)
FDA (14050)
Job Trends (12199)
News (248049)
Policy (24394)
Tag
Academia (2362)
Accelerated approval (4)
Adcomms (16)
Allergies (86)
Alliances (36847)
ALS (83)
Alzheimer's disease (1188)
Antibody-drug conjugate (ADC) (104)
Approvals (14085)
Artificial intelligence (243)
Autoimmune disease (19)
Automation (7)
Bankruptcy (191)
Best Places to Work (10290)
BIOSECURE Act (11)
Biosimilars (59)
Biotechnology (66)
Bladder cancer (65)
Brain cancer (25)
Breast cancer (255)
Cancer (2006)
Cardiovascular disease (147)
Career advice (766)
Career pathing (21)
CAR-T (140)
Cell therapy (356)
Cervical cancer (15)
Clinical research (54034)
Collaboration (718)
Company closure (1)
Compensation (242)
Complete response letters (15)
COVID-19 (1999)
CRISPR (34)
C-suite (208)
Cystic fibrosis (79)
Data (2021)
Decentralized trials (2)
Denatured (18)
Depression (39)
Diabetes (226)
Diagnostics (5462)
Digital health (15)
Diversity (5)
Diversity, equity & inclusion (23)
Drug discovery (102)
Drug pricing (67)
Drug shortages (24)
Duchenne muscular dystrophy (71)
Earnings (50624)
Editorial (28)
Employer branding (12)
Employer resources (71)
Events (75068)
Executive appointments (625)
FDA (15236)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (6)
Funding (605)
Gene editing (79)
Generative AI (19)
Gene therapy (216)
GLP-1 (553)
Government (3661)
Grass and pollen (3)
Guidances (53)
Healthcare (16879)
Huntington's disease (12)
IgA nephropathy (23)
Immunology and inflammation (72)
Indications (28)
Infectious disease (2106)
Inflammatory bowel disease (122)
Inflation Reduction Act (5)
Influenza (45)
Intellectual property (81)
Interviews (101)
IPO (10843)
IRA (23)
Job creations (2259)
Job search strategy (683)
Kidney cancer (7)
Labor market (16)
Layoffs (268)
Leadership (10)
Legal (5016)
Liver cancer (70)
Lung cancer (287)
Lymphoma (132)
Machine learning (6)
Management (24)
Manufacturing (199)
MASH (56)
Medical device (13687)
Medtech (13690)
Mergers & acquisitions (13241)
Metabolic disorders (559)
Multiple sclerosis (87)
NASH (14)
Neurodegenerative disease (76)
Neuropsychiatric disorders (20)
Neuroscience (1669)
NextGen: Class of 2025 (5872)
Non-profit (4388)
Now hiring (32)
Obesity (290)
Opinion (144)
Ovarian cancer (73)
Pain (84)
Pancreatic cancer (74)
Parkinson's disease (132)
Partnered (16)
Patents (173)
Patient recruitment (110)
Peanut (47)
People (44799)
Pharmaceutical (26)
Pharmacy benefit managers (13)
Phase I (16581)
Phase II (23785)
Phase III (18141)
Pipeline (1005)
Policy (84)
Postmarket research (1983)
Preclinical (6123)
Press Release (53)
Prostate cancer (91)
Psychedelics (22)
Radiopharmaceuticals (216)
Rare diseases (295)
Real estate (3971)
Recruiting (27)
Regulatory (17520)
Reports (21)
Research institute (2125)
Resumes & cover letters (183)
Rett syndrome (4)
RNA editing (2)
RSV (24)
Schizophrenia (65)
Series A (102)
Series B (75)
Service/supplier (4)
Sickle cell disease (41)
Special edition (6)
Spinal muscular atrophy (124)
Sponsored (21)
Startups (2741)
State (1)
Stomach cancer (10)
Supply chain (51)
Tariffs (19)
The Weekly (13)
Vaccines (511)
Venture capitalists (20)
Weight loss (181)
Women's health (20)
Worklife (8)
Date
Last 7 days (689)
Last 30 days (1938)
Last 365 days (26096)
2025 (8481)
2024 (28463)
2023 (33106)
2022 (42655)
2021 (45672)
2020 (44800)
2019 (41456)
2018 (31164)
2017 (24904)
2016 (22867)
2015 (26803)
2014 (19961)
2013 (16192)
2012 (17456)
2011 (17781)
2010 (16049)
Location
Africa (459)
Alabama (50)
Alaska (6)
Arizona (150)
Arkansas (11)
Asia (31294)
Australia (4961)
California (4672)
Canada (1585)
China (476)
Colorado (221)
Connecticut (236)
Delaware (135)
Europe (64857)
Florida (756)
Georgia (164)
Idaho (49)
Illinois (464)
India (21)
Indiana (291)
Iowa (8)
Japan (143)
Kansas (85)
Kentucky (15)
Louisiana (9)
Maine (36)
Maryland (802)
Massachusetts (3408)
Michigan (162)
Minnesota (379)
Mississippi (2)
Missouri (68)
Montana (29)
Nebraska (23)
Nevada (46)
New Hampshire (69)
New Jersey (1382)
New Mexico (26)
New York (1325)
North Carolina (788)
North Dakota (7)
Northern California (2053)
Ohio (178)
Oklahoma (10)
Oregon (30)
Pennsylvania (1113)
Puerto Rico (12)
Rhode Island (31)
South America (712)
South Carolina (22)
South Dakota (1)
Southern California (1812)
Tennessee (92)
Texas (750)
United States (18317)
Utah (166)
Virginia (120)
Washington D.C. (51)
Washington State (397)
West Virginia (3)
Wisconsin (50)
507,121 Results for "multi radiance medical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioMidwest
Multi Radiance Medical Breaks New Ground in Fibromyalgia Pain Relief with the First FDA-Cleared Therapeutic Laser
Pioneering the frontier of super-pulsed laser technology, Multi Radiance Medical highlights the impact of FibroLux Therapeutic Laser, one of the first and only FDA-cleared therapeutic lasers designed to alleviate pain specifically for individuals battling Fibromyalgia Syndrome.
February 1, 2024
·
4 min read
Press Releases
Radiance Biopharma Enters Exclusive License For ROR-1 Targeted Antibody Drug Conjugate
February 20, 2025
·
4 min read
Press Releases
Radiance Announces First Patient Dosing in Phase 1 Clinical Trial of its Next Generation ROR-1 Targeted ADC for Hematologic and Solid Malignancies
April 15, 2025
·
2 min read
Press Releases
Cineca to House Italy’s Most Powerful Quantum Computer IQM Radiance 54
March 17, 2025
·
2 min read
Press Releases
Radiance Announces FDA Clearance of IND Application for a Phase 1 Clinical Trial of RB-164™, an ROR-1 Targeted ADC, for Hematologic and Solid Malignancies
March 31, 2025
·
2 min read
Press Releases
REPEAT -- Radiance Announces FDA Clearance of IND Application for a Phase 1 Clinical Trial of RB-164™, an ROR-1 Targeted ADC, for Hematologic and Solid Malignancies
April 1, 2025
·
2 min read
Press Releases
Radiance has been selected to Present at the 2025 Biotech Showcase™ Alongside the J.P. Morgan Healthcare Conference
January 16, 2025
·
1 min read
Press Releases
Telomir Pharmaceuticals Achieves Breakthrough in Silver Ion Stabilization, Unlocking a Multi-Billion-Dollar Medical Market
February 24, 2025
·
6 min read
Press Releases
AbTherx and Rondo Therapeutics Announce Multi-Program Antibody Discovery Collaboration
April 23, 2025
·
2 min read
Policy
Multi Radiance Medical Therapeutic Laser Receives FDA Clearance for The Treatment of Pain Associated with Fibromyalgia
Multi Radiance Medical has become the first laser therapy manufacturer to receive FDA clearance to treat pain associated with fibromyalgia.
October 4, 2022
·
3 min read
1 of 50,713
Next
